Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4550512014 | Tepotinib only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4550513016 | Product containing only tepotinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tepotinib only product in oral dose form | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Tepotinib only product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Tepotinib only product in oral dose form | est un(e) (attribut) | Product containing tepotinib in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Tepotinib only product in oral dose form | a pour principe actif (attribut) | Tepotinib | true | Inferred relationship | Some | 1 | |
| Tepotinib only product in oral dose form | est un(e) (attribut) | Tepotinib only product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely tepotinib (as tepotinib hydrochloride) 225 milligram/1 each conventional release oral tablet (clinical drug) | est un(e) (attribut) | True | Tepotinib only product in oral dose form | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR